The differential diagnosis for a cardiac mass includes primary and metastatic neoplasms. While primary cardiac tumors are rare, metastatic disease to the heart is a common finding in cancer patients. Several "tumor-like" processes can mimic a true cardiac neoplasm with accurate diagnosis critical at guiding appropriate management. We present a pictorial essay of the most common benign cardiac masses and "mass-like" lesions with an emphasis on magnetic resonance imaging features.
INTRODUCTION
Primary cardiac neoplasms are rare and usually benign, with a reported frequency of 0.02%. [1, 2] Metastatic disease to the heart is common, occurring in 10% of cancer patients. [3] Transthoracic ultrasound has long been the primary modality for identifying and evaluating cardiac masses. The technology is noninvasive, cheap, widely available, and allows for real-time imaging for mass mobility. Evaluation may be limited due to patient body-habitus, a poor sonographic window, or operator inexperience. Contrast resolution on ultrasound is also relatively poor. Magnetic resonance imaging (MRI) combines noninvasive multiplanar imaging and the ability to acquire functional information with excellent contrast resolution. A regular heart rate and electrocardiographic gating are crucial for acquiring diagnostic images.
Although there is overlap of the MRI characteristics of several cardiac masses, MRI can be diagnostic in several settings and provide useful information in others. Lipomas, fibromas, and hemangiomas as well as thrombus or lipomatous hypertrophy may be confidently diagnosed with MRI. Heterogeneous signal, enhancement, necrosis, extra-cardiac spread, or pericardial effusion may be identified, with the absence of these findings suggesting benignity. [4] Electrocardiogram (ECG)-gated T1-weighted spin-echo (SE) images are initially acquired in the axial plane for the (a) TTE shows a small mobile mass attached to a cardiac valve with "shimmer" artifact (white arrow) compatible with a papillary fibroelastoma, (c) SSFP cine shows the mass was attached to the mitral valve by a short stalk and mobile with turbulent blood flow, (c) On SSFP the mass was hypointense and (d) post contrast T1-weighted image shows the mass was also hypointense (black arrow) and (e) T2-weighted imaging reveals the mass is inconspicuous. d c b a e evaluation of suspected cardiac masses. Sagittal or coronal plane sequences may also be obtained for further delineation of tumor extent. T2-weighted SE images help enhance the contrast between tumor and myocardium and aid in identifying possible cystic or necrotic features. Gadopentetic acid (Gd-DTPA) is administered to improve contrast between tumor and myocardium on T1-weighted images. Fat-saturation techniques are effective for characterizing lipomas. Steady-state free precession (SSFP) sequences display the blood pool with high signal intensity (white blood imaging). Cine MR SSFP images provide valuable information about the movement of masses relative to other cardiovascular structures. [5] 
BENIGN MASSES

Myxoma
Approximately 50% of primary cardiac neoplasms are myxomas, with 75% of these originating from the left atrium. [2, 6] On cine imaging, (http://www. clinicalimagingscience.org/articles/2013/3/1/images/ JClinImagingSci_2013_3_1_34_117458_sm30.gif Fig 1a) a narrow stalk that attaches to the inter-atrial septum or prolapse of the myxoma across the atrioventricular valve may be observed [ Figure 1a ]. Myxomas are often isointense to myocardium on SSFP/T1-weighted and hypointense on T2-weighted imaging [ Figure 1b and c]. Variable heterogeneous enhancement may be seen after contrast administration [ Figure 1d ]. On transthoracic echocardiogram (TTE), myxomas appear lobular and heterogeneously echogenic with a characteristic stalk and relative mobility [ Figure 1e ]. In patients with a cardiac myxoma, a careful history and physical assessment is advised as myxomas of the heart, skin, or breast can be seen in patients with spotty skin pigmentation, schwannomas, and endocrine disorders, including Cushing syndrome. [7] This autosomal dominant condition was originally described, nearly 3 decades ago, as being most often due to a mutation in the tumor suppressor gene PRKAR1A that encodes the protein kinase A regulatory subunit. [8] 
Papillary fibroelastoma
Papillary fibroelastomas are the most common primary cardiac tumor to originate from a cardiac valve, and the second most common tumor overall. [2] There is a slight predilection for fibroelastomas to occur on the aortic and mitral valve. While left-sided tumors may present with symptoms related to systemic embolization, right-sided tumors are usually asymptomatic. [9] Papillary fibroelastomas are typically seen on TTE as a small mobile mass attached to a cardiac valve with a characteristic "shimmer" artifact at the interface of the mass with adjacent blood [ Figure 2a ]. [10] Visualizing papillary fibroelastomas on MR has traditionally been limited due to the typically small size at detection. If visualized on MRI cine SSFP imaging, the mass would typically be mobile and attached to a cardiac valve by a short stalk with adjacent turbulent blood flow [ Figure 2b ]. The signal characteristics of papillary fibroelastomas are not well-reported. A case at our institution presented as a hypointense mass on SSFP and post-contrast T1-weighted imaging was conspicuous due to bright blood signal on these sequences which outlined the mass [ Figure  2c and d]. The mass was not well-visualized on T2-weighted images [ Figure 2e ].
Lipoma
Cardiac lipomas are rare benign primary cardiac neoplasms of mature adipose tissue that may originate from the epicardium or endocardium. When cardiac lipomas 
Fibroma
Fibromas are rare benign fibrous tumors that primarily occur within the interventricular septum or left ventricular free wall of children. [2] On cine imaging (http://www. clinicalimagingscience.org/articles/2013/3/1/images/ JClinImagingSci_2013_3_1_34_117458_sm33.gif Fig 4a) , fibromas appear as a non-contractile mass that often narrows the ventricular cavity [ Figure 4a ]. The fibrous nature of the tumor produces hypointense signal on SSFP and T2-weighted imaging [ Figure 4b and c]. While little or no tumoral enhancement is often reported, enhancement patterns are variable and include heterogeneous, homogeneous, and peripheral enhancement. [11] Hemangioma Hemangiomas account for approximately 5% of cardiac tumors and may occur in either the endocardium, myocardium, or epicardium. [12] On MR cine SSFP imaging (http://www.clinicalimagingscience.org/articles/2013/3/1/ images/JClinImagingSci_2013_3_1_34_117458_sm34. gif Fig 5a) a cardiac hemangioma may appear as a non-mobile, non-contractile mass without predilection for a given cardiac chamber [ Figure 5a ]. On T1-weighted imaging, hemangiomas are isotense secondary to slow flow with hyperintense signal on T2-weighted imaging [ Figure 5b and c]. Strong heterogeneous to homogeneous enhancement is observed after contrast administration [ Figure 5d ].
Paraganglioma
Paragangliomas are rare tumors of chromaffin cells that can present with symptoms related to catecholamine release, most commonly hypertension. A cardiac location for paragangliomas are exceedingly rare, with the roof of the left atrium and the inter-atrial septum the most common locations, when they do occur. [13] Paragangliomas are hypo-to iso-intense 
"MASS-LIKE" LESIONS Thrombus
Intra-cardiac thombi are relatively common and may be seen in the setting of atrial fibrillation or after myocardial infarction or central line placement. Transthoracic or transesophageal ultrasound combined with clinical correlation is often sufficient to arrive at the correct diagnosis. In the rare case where differentiating between thrombus and true mass is difficult, cardiac MRI can provide valuable information.
Delayed enhancement using a segmented inversion recovery sequence [ Figure 6a ] increases the sensitivity for thrombus detection compared to MRI cine SSFP sequences. [14] On cine imaging (http://www. clinicalimagingscience.org/articles/2013/3/1/images/ JClinImagingSci_2013_3_1_34_117458_sm35.gif Fig  6b) , a location in an area of wall motion abnormality or in the left atrial appendage is suggestive of thrombus [ Figure 6b ]. The morphological appearance is clinically relevant as the risk for embolism is significantly higher with mobile or protruding thrombi compared to flat thrombi. [15] The signal on T1-and T2-weighted images may be variable and heterogeneous. Increasing the inversion times to 400-600 ms can increase contrast resolution between thrombus and myocardium during inversion recovery sequences (http://www. clinicalimagingscience.org/articles/2013/3/1/images/ JClinImagingSci_2013_3_1_34_117458_sm36.gif Fig 6c) [ Figure 6c ].
Lipomatous hypertrophy
Lipomatous hypertrophy of the intra-atrial septum is septal infiltration by non-encapsulated adipose, seen almost exclusively in the setting of obesity. Normally the inter-atrial septum is less than 1 cm in thickness, but thickening of the septum caudal to the fossa ovale to greater than 7 cm may be seen with lipomatous hypertrophy. [16] MRI cine SSFP sequence demonstrates non-encapsulated hyper-intense septal thickening [ Figure 7a ]. Lipomatous hypertrophy is hyper-intense on T1-and T2-weighted sequences and does not enhance after contrast administration [ Figure 7b -d].
CONCLUSION
MRI can effectively identify imaging characteristics that suggest the type of cardiac tumor, location, mobility, base thickness, infiltration, and enhancement. MRI can also differentiate a true mass from an intra-cardiac thrombus, which will need very different management. As experience with cardiac MRI continues to increase, the rare cardiac masses will become less of a diagnostic dilemma. 
